IMCC Price To Operating Cash Flows Ratio from 2010 to 2024

IMCC Stock  USD 2.59  0.02  0.77%   
Im Cannabis' Price To Operating Cash Flows Ratio is increasing over the years with very volatile fluctuation. Price To Operating Cash Flows Ratio is expected to dwindle to -4.6. During the period from 2010 to 2024 Im Cannabis Price To Operating Cash Flows Ratio annual values regression line had coefficient of variation of (199.44) and r-squared of  0.00000196. View All Fundamentals
 
Price To Operating Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
(4.38)
Current Value
(4.60)
Quarterly Volatility
191.87857413
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Im Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Im Cannabis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 3.9 M or Total Revenue of 51.2 M, as well as many indicators such as Price To Sales Ratio of 0.69, Dividend Yield of 0.0 or PTB Ratio of 2.32. IMCC financial statements analysis is a perfect complement when working with Im Cannabis Valuation or Volatility modules.
  
Check out the analysis of Im Cannabis Correlation against competitors.

Latest Im Cannabis' Price To Operating Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Operating Cash Flows Ratio of Im Cannabis Corp over the last few years. It is Im Cannabis' Price To Operating Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Im Cannabis' overall financial position and show how it may be relating to other accounts over time.
Price To Operating Cash Flows Ratio10 Years Trend
Very volatile
   Price To Operating Cash Flows Ratio   
       Timeline  

IMCC Price To Operating Cash Flows Ratio Regression Statistics

Arithmetic Mean(96.21)
Coefficient Of Variation(199.44)
Mean Deviation117.30
Median(23.31)
Standard Deviation191.88
Sample Variance36,817
Range728
R-Value0
Mean Square Error39,649
R-Squared0.00000196
Significance1.00
Slope0.06
Total Sum of Squares515,443

IMCC Price To Operating Cash Flows Ratio History

2024 -4.6
2023 -4.38
2022 -4.43
2021 -3.33
2020 -296.87
2019 -43.79
2018 -730.9

About Im Cannabis Financial Statements

Im Cannabis stakeholders use historical fundamental indicators, such as Im Cannabis' Price To Operating Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although Im Cannabis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Im Cannabis' assets and liabilities are reflected in the revenues and expenses on Im Cannabis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Im Cannabis Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Operating Cash Flows Ratio(4.38)(4.60)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:
Check out the analysis of Im Cannabis Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.13)
Revenue Per Share
22.335
Quarterly Revenue Growth
0.117
Return On Assets
(0.17)
Return On Equity
(1.12)
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.